Published in Medical Patent Law Weekly, December 30th, 2009
Mintz Levin advised Protalix on the IP aspects of the transaction. The patent work was led by Ivor Elrifi, Co-Chair of the Intellectual Property Section who has been recognized as one of the top intellectual property and patent litigation lawyers in the life sciences sector, as well as David Johnson, a member in the firm's Intellectual Property Section who focuses primarily in the area of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly